Pimobendan 74150-27-9 Metabolism PDE inhibitor
Utu:T/T, L/C
Takenga Hua:Haina
Tauranga Tukunga:Beijing/Shanghai/Hangzhou
Raupapa (MOQ):1g
Wā Arataki:3 nga ra mahi
Te kaha whakaputa:1kg/marama
Tikanga rokiroki:Whakaorangia ki te waahi makariri, maroke, te pāmahana rūma.
rauemi mōkihi:pounamu, pounamu
Rahi mōkihi:1g/pounamu, 5/putea, 10g/pounamu, 50g/pounamu, 500g/pounamu
Nga korero haumaru:UN 2811 6.1/PG 3
Kupu Whakataki
Ko Pimobendan, he rongoa kararehe.Ko te sensitizer konupūmā me te aukati whiriwhiri o phosphodiesterase 3 (PDE3) ki pai inotropic me vasodilator pānga.
Ka whakamahia te Pimobendan ki te whakahaere i te ngoikore o te ngakau i roto i nga kuri, ko te nuinga o te mate na te mate myxomatous mitral valve (e mohiotia ana i mua ko te endocardiosis), ko te cardiomyopathy tohanga ranei.Kua whakaatuhia e nga rangahau ko te pimobendan te whakanui ake i te wa ora me te whakapai ake i te kounga o te oranga o nga turoro kuri he ngoikore te ngakau tuarua ki te mate mitral valve ina whakaritea ki te benazepril, he aukati ACE.
Whakatakotoranga (USP43)
| Tūemi | Whakatakotoranga |
| Te ahua | Te paura ma, paku kowhai ranei, hygroscopic |
| Mp | Tata ki te 242 ℃ |
| Wairewa | Kare e rewa i roto i te wai, he memeha noa ki te dimethylformamide, he paku whakarewa ki te acetone me te methanil. |
| Tautuhinga | Spectrophotometry whakaurunga infrared, Whakatauritenga pimobendan CRS. |
| Ko te wa pupuri o te tihi nui o te otinga Tauira e rite ana ki tera o te otinga kararehe Paerewa, pera i riro mai i te whakamatautau Organic poke. | |
| Nga konganuku taumaha | ≤10ppm |
| Te maramara | P90 ≤ 25μ m |
| Te rahi o te matūriki | 20-80 mata |
| Te toenga whakarewa | ≤ 500ppm |
| Wai | ≤ 1.0% |
| Te whakamatautau | 98.0%~102.0% |
| Te pungarehu ngongo | ≤ 0.10% |
| Nga matū e pa ana (HPLC) | |
| poke A | ≤ 0.10% |
| poke B | ≤ 0.10% |
| Tetahi atu poke | ≤ 0.10% |
| Te poke katoa | ≤ 0.20% |
